Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patients

PLoS One. 2014 Jun 10;9(6):e99281. doi: 10.1371/journal.pone.0099281. eCollection 2014.

Abstract

Objective and background: Although many studies on evaluating the safety of liver resection in obese patients have been conducted, the results remain contradictory. The aim of our study was to investigate the safety of overweight and obese patients undergoing liver resection for hepatitis B-related hepatocellular carcinoma in a large sample.

Methods: In a retrospective cohort with 1543 hepatitis B-related hepatocellular carcinoma patients, the subjects were stratified into four groups according to their body mass index(BMI): obesity(BMI≥28), overweight(BMI:24.0-27.9), normal weight(BMI:18.5-23.9) and underweight(BMI<18.5). The Dindo-Clavien classification system was used for grading complications. Clinical characteristics and operative outcomes were compared among the four groups. Risk factors for postoperative complications were evaluated by multivariate analysis.

Results: According to the category criteria of the Working Group on Obesity in China (WGOC) criteria, 73(4.7%) obese, 412(26.7%) overweight, 982(63.6%) normal weight and 76(4.9%) underweight patients were included in our cohort. Overweight and obese patients had more preoperative comorbidities such as hypertension(P<0.001). Mortality, total complications and complications classified by Clavien system were similar among the four groups except that the underweight patients had fewer total complications. However, postoperative wound complication was more common in overweight and obese patients(6.3% vs 2.5%,P<0.001,11.0% vs 2.5%,P = 0.001). Multivariate analysis revealed that BMI was not an independently significant factor for postoperative complications.

Conclusions: Liver resection for obese and overweight patients is safe and BMI itself is not a risk factor for mortality and morbidity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Carcinoma, Hepatocellular / complications*
  • Carcinoma, Hepatocellular / surgery*
  • Carcinoma, Hepatocellular / virology
  • Female
  • Hepatectomy / adverse effects*
  • Hepatitis B / complications*
  • Humans
  • Liver Neoplasms / complications*
  • Liver Neoplasms / surgery*
  • Liver Neoplasms / virology
  • Logistic Models
  • Male
  • Middle Aged
  • Obesity / complications*
  • Perioperative Care
  • Postoperative Complications / etiology
  • Prognosis
  • Treatment Outcome

Grants and funding

This work was supported by National Science and Technology Major Project of China, No. 2012ZX10002-016 and No. 2012ZX10002-017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.